Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Metadata
Title
Overexpression of the p16 Cell Cycle Inhibitor in Breast Cancer is Associated with a More Malignant Phenotype
Authors
Karin Milde-Langosch
Ana-Maria Bamberger
Gabriele Rieck
Bianca Kelp
Thomas Löning
Publication date
01-05-2001
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1010623308275

Other articles of this Issue 1/2001

Breast Cancer Research and Treatment 1/2001 Go to the issue

Conference Report

p27 Expression Correlates with Short-Term, but not with Long-Term Prognosis in Breast Cancer

Conference Report

Contralateral Breast Cancer: Molecular Differentiation Between Metastasis and Second Primary Cancer

Conference Report

Sealing of Postoperative Axillary Leakage After Axillary Lymphadenectomy Using a Fibrin Glue Coated Collagen Patch: a Prospective Randomised Study

Conference Report

Incidence of Second Primary Breast Cancer Among Women with a First Primary in Manitoba, Canada

Conference Report

Low pO2 and β-Estradiol Induce VEGF in MCF-7 and MCF-7-5C Cells: Relationship to in vivo Hypoxia

Conference Report

Predictability of Monthly and Yearly Rhythms of Breast Cancer Features
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits